ArticlebioRxiv : the preprint server for biology2026
PARiS: Probabilistic Assignment and Repartitioning of isomiR Sequences: A data-driven method for denoising isomiR read count data.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
MicroRNAs (miRNAs) are non-coding RNAs, approximately 18 - 24 nucleotides in length, with important gene regulatory functions. In small RNA sequencing (sRNA-seq), observed isoforms of miRNA, called isomiRs, arise from my biological and technical processes. Alterations in isomiR expression has been linked to a wide variety of human diseases, from cancers to neurological diseases. However, it is difficult to distinguish between technical and biological isomiRs. We present PARiS, an algorithm for the Probabilistic Assignment and Repartitioning of isomiR Sequences, that identifies technical error isomiRs in sRNA-seq data and reassigns them to their most likely biological source. We assess the ability of PARiS to identify and remove error isomiR sequences in a realistic simulation study. Additionally, we compare PARiS to alternative approaches, focusing on downstream miRNA-level differential expression analysis in a variety of settings, including a set of simulated datasets, an experimental benchmark dataset, and three colorectal adenocarcinoma cell lines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.